Evaluating The Effect Of Morphine On Obstructive Sleep Apnea
Funder
National Health and Medical Research Council
Funding Amount
$534,303.00
Summary
Prescription opiate poisoning deaths have increased substantially in recent years which may be worsened by population increases in obesity and related obstructive sleep apnea. However, no proper clinical trial has ever investigated the effect of an opiate on obstructive sleep apnea, which is the aim of the proposed trial. The study will be important in understanding ways to reduce opiate realted deaths and may also provide insights into new treatment methods for snoring and sleep apnea.
Determining Patterns Of Cessation And Relapse In A Cohort Of People Who Inject Drugs
Funder
National Health and Medical Research Council
Funding Amount
$1,189,791.00
Summary
Harms related to injecting drug use represent the bulk of the burden attributable to illicit drugs in Australia. In this study we will determine rates of long term cessation of injecting drug use, and relapse, and key drivers of these outcomes such as drug treatment or housing provision. Findings will inform policy and practice around injecting drug use in Australia over the coming decade.
Toward A Comprehensive Picture Of The Epidemiology Of Alcohol And Illicit Drug Use Disorders: Novel Analyses Of The World Health Organization's World Mental Health Surveys
Funder
National Health and Medical Research Council
Funding Amount
$734,155.00
Summary
Alcohol and illicit drug use are among the biggest risk factors for disease burden, but there is much that is not known about the natural history of substance use. This study involves analysis of data from the WHO World Mental Health Survey (WMHS) initiative, which contains data on >160,000 participants from more than 31 countries. This study will examine the patterns and predictors of substance use problems, using novel statistical techniques predict who is at greatest risk.
A New, Low-cost E-health Treatment For Alcohol Use Disorder Using Mental Imagery
Funder
National Health and Medical Research Council
Funding Amount
$895,032.00
Summary
This project offers the first large-scale test of phone-based Functional Imagery Training (FIT), a new, low-cost way to help people change behaviours using mental imagery, regardless of where they live. The trial addresses Alcohol Use Disorder—a common problem with substantial health and social impacts, comparing FIT with verbal motivational treatments, and testing effects on alcohol use and quality of life over 12 months. Cost-effectiveness and predictions of outcome are also examined.
Combating Escalating Harms Associated With Pharmaceutical Opioid Use
Funder
National Health and Medical Research Council
Funding Amount
$925,767.00
Summary
Increases in opioid use have been accompanied by increased opioid harms. But there is a lack of population-level evidence about drivers of long-term prescribed opioid use, dependence, overdose and other harms. Using linked data, we will fill these gaps using a cohort of all people in NSW prescribed opioids since 2002, linked to datasets containing information on health, social and health service utilisation, that will permit a comprehensive assessment of the risks of all prescribed opioids.
Improving Alcohol Treatment Outcomes: The Impact Of Client, Intervention And System Variables On Treatment Outcomes.
Funder
National Health and Medical Research Council
Funding Amount
$1,525,879.00
Summary
Patient outcomes are significantly influenced by a number of factors including the characteristics of the patient, the type of treatment provided, and the characteristics of the system in which care is delivered. This study aims to determine how these factors influence outcomes for people seeking treatment for alcohol dependence. It will provide critical information for policy makers on which to base minimum service standards.
Efficacy Of Education And Advice Delivered By Text Message To Aid Smoking Cessation
Funder
National Health and Medical Research Council
Funding Amount
$538,395.00
Summary
A high proportion of smokers indicate a desire to stop smoking and report having made attempts to quit. However, most attempts are not successful and new methods are needed to support motivated smokers and improve success rates. This project evaluates the use of text messages to deliver advice and support to smokers motivated to stop smoking. We aim to understand if and how this promosing new intervention helps smokers to quit.
Exploring The Efficacy And Biobehavioural Basis Of Baclofen In The Treatment Of Alcoholic Liver Disease.
Funder
National Health and Medical Research Council
Funding Amount
$661,197.00
Summary
Alcoholic liver disease (ALD) is the main cause of death from alcohol consumption. Early detection of the disease and subsequent abstinence from alcohol can prevent death and disability. Current medications to help control alcohol consumption are not suitable for use in this patient population owing to the risk of liver side-effects. This study investigates the novel use of an existing medication, baclofen, to safely help maintain abstinence from alcohol in patients suffering from ALD.
Australian Longitudinal Study Of Heroin Dependence: An 18-20yr Prospective Cohort Study Of Mortality, Abstinence, And Psychiatric And Physical Health Comorbidity
Funder
National Health and Medical Research Council
Funding Amount
$1,210,319.00
Summary
The burden associated with heroin dependence is undeniable. But little is known about the natural history and long-term course of heroin dependence; knowledge that is critical for informing the development of new treatment interventions, health care planning and service delivery. We propose to extend our study of 615 Australians with heroin dependence, recruited in 2001-2002, to 18-20 years follow-up to answer critical questions about the long-term impact of this condition.
Defining The Clinical Role Of Topiramate In The Treatment Of Alcohol Dependence In Australia
Funder
National Health and Medical Research Council
Funding Amount
$718,836.00
Summary
We urgently require new strategies for the treatment of alcohol dependence. The effectiveness of currently approved alcohol medications is limited. Emerging data suggests that topiramate has robust effectiveness and that better medicine selection is possible for patients based on their genotype. We propose to conduct a double-blind randomised controlled trial to examine the clinical and cost effectiveness of topiramate using a genetically based personalised approach.